44.48USD-2.78%Mkt Cap: 5.65B $P/E: —1d ago
10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia P…
Industry Peers
Health Information Services$32.06BUSDP/E 35.0
$13.38BUSDP/E 88.5
$9.62BUSD
$8.27BUSDP/E 37.0
$6.65BUSD
$4.44BUSDP/E 34.6
$3.43BUSDP/E 160.1
$2.24BUSD
$2.14BUSDP/E 106.8
$1.71BUSD
$1.41BUSD
$1.17BUSD
$1.13BUSD
$1.06BUSDP/E 52.0
$874.42MUSDP/E Infinity
$845.49MUSDP/E 43.2
$672.72MUSDP/E 68.1
$637.77MUSD
$581.77MUSDP/E 27.4
$584.81MUSD
$552.27MUSDP/E 13.1
$524.39MUSD
$516.62MUSD
$494.46MUSDP/E 56.3
$460.71MUSDP/E 25.8
$446.52MUSDP/E 25.4
$393.58MUSDP/E 90.5
$368.70MUSDP/E 45.6
$321.33MUSD
$230.81MUSDP/E 14.1
$224.12MUSDP/E 18.2
$217.63MUSD
$182.96MUSD
$156.35MUSDP/E 39.4
$168.48MUSD
$148.67MUSDP/E 29.6
$123.72MUSDP/E Infinity
$124.79MUSDP/E 18.5
$113.48MUSDP/E 25.4
$99.01MUSDP/E 17.9
$86.66MUSD
$65.63MUSDP/E 11.3
$62.29MUSDP/E 22.6
$57.34MUSD
$47.87MUSDP/E 57.6
$49.50MUSD
$40.55MUSDP/E 38.7
$39.14MUSD
$31.93MUSD
$26.93MUSDP/E 26.0
$22.91MUSDP/E 54.8
$20.17MUSD
$18.43MUSD
$12.99MUSD
$13.69MUSD
$12.35MUSD
$11.72MUSD
$9.78MUSDP/E 15.1
$6.67MUSD
$6.50MUSD
$5.63MUSD
$4.88MUSD
$3.78MUSDP/E Infinity
$3.83MUSDP/E 0.0
$3.40MUSD
$2.98MUSD
$2.70MUSD
$2.16MUSDP/E Infinity
$693.4KUSD
$548.9KUSDP/E 0.0
$282.6KUSD
—
—
—
EYES
Corgi Data & Surveillance ETF—P/E 30.8
CRY
GraniteShares YieldBOOST CRCL ETF—
Indicators:|
Key Statistics
Company
Market Cap5.65B $
Enterprise Value5.19B $
Revenue (TTM)638.78M $
Gross Profit443.88M $
Net Income (TTM)-43.54M $
Revenue/Share5.063 USD
Last Price44.48 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees1.2K
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISINUS88025U1097
Valuation
P/E (Trailing)—
P/E (Forward)215.22
PEG—
EV/EBITDA-169.18
EV/Revenue8.12
P/S8.84
P/B7.13
EPS (TTM)-0.17
EPS (Forward)0.21
52W Range
11.1695% of range46.32
52W High46.32 USD
52W Low11.16 USD
Profitability
Gross Margin69.05%
Oper. Margin-11.30%
EBITDA Margin-4.80%
Profit Margin-6.77%
ROE-5.47%
ROA-4.18%
Growth
Revenue Growth-2.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF136.05M $
CapEx (TTM)5.93M $
FCF Margin19.50%
FCF Yield2.21%
Net Debt-458.46M $
Net Debt/EBITDA14.95
Balance Sheet
Debt/Equity0.11
Current Ratio5.90
Quick Ratio5.25
Book Value/Sh6.236 USD
Cash/Share4.252 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.3 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)37.15 USD
Upside (mean)-16.5%
Target Range20.00 USD – 50.00 USD
$20.00-16.5% to mean$50.00
# Analysts13
Ownership
Shares Out.116.88M
Float114.82M
Insiders1.67%
Institutions112.01%
Short Interest
Short Ratio4.5d
Short % Float19.11%
Short % Out.12.87%
Shares Short16.34M
Short (prev mo.)16.49M
Technical
SMA 5030.65 (+45.1%)
SMA 20021.29 (+108.9%)
Beta2.04
S&P 52W Chg20.25%
Avg Vol (30d)3.32M
Avg Vol (10d)3.08M
Technical Indicators
RSI (14)69.6
MACD4.0130
MACD Signal3.5685
MACD Hist.+0.4445
BB Upper47.41 USD
BB Middle38.28 USD
BB Lower29.14 USD
BB Width47.73%
ATR (14)2.651 USD
Vol Ratio (20d)1.31x